Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 39% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7087.92 | 1445 / 1445 | 100% | 92.92 | 183 / 183 |
brain | 100% | 9132.22 | 2641 / 2642 | 100% | 75.33 | 705 / 705 |
stomach | 100% | 9052.44 | 359 / 359 | 99% | 61.70 | 284 / 286 |
intestine | 100% | 8777.97 | 966 / 966 | 99% | 58.25 | 521 / 527 |
thymus | 100% | 5124.31 | 652 / 653 | 99% | 47.12 | 599 / 605 |
pancreas | 98% | 3988.96 | 321 / 328 | 100% | 95.69 | 178 / 178 |
uterus | 100% | 7614.16 | 170 / 170 | 98% | 52.60 | 449 / 459 |
lung | 99% | 3412.18 | 572 / 578 | 99% | 60.35 | 1139 / 1155 |
adrenal gland | 100% | 8109.79 | 258 / 258 | 97% | 66.75 | 224 / 230 |
prostate | 100% | 5089.67 | 245 / 245 | 97% | 33.21 | 485 / 502 |
bladder | 100% | 7227.38 | 21 / 21 | 96% | 49.31 | 486 / 504 |
skin | 97% | 6356.78 | 1763 / 1809 | 98% | 69.65 | 464 / 472 |
ovary | 100% | 4041.27 | 180 / 180 | 94% | 42.15 | 403 / 430 |
breast | 87% | 4455.00 | 400 / 459 | 99% | 114.64 | 1110 / 1118 |
kidney | 100% | 6734.89 | 89 / 89 | 86% | 35.04 | 778 / 901 |
liver | 88% | 2873.14 | 200 / 226 | 76% | 32.56 | 307 / 406 |
eye | 0% | 0 | 0 / 0 | 100% | 55.75 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 90.11 | 29 / 29 |
spleen | 100% | 5595.75 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 64.70 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 45.67 | 1 / 1 |
blood vessel | 96% | 2659.31 | 1275 / 1335 | 0% | 0 | 0 / 0 |
adipose | 83% | 2145.83 | 1001 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 73% | 2775.80 | 678 / 929 | 0% | 0 | 0 / 0 |
heart | 72% | 1574.90 | 622 / 861 | 0% | 0 | 0 / 0 |
muscle | 4% | 57.97 | 29 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045672 | Biological process | positive regulation of osteoclast differentiation |
GO_0045121 | Cellular component | membrane raft |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | EEIG1 |
Protein name | Early estrogen-induced gene 1 protein (EEIG1) |
Synonyms | C9orf132 FAM102A |
Description | FUNCTION: Key component of TNFSF11/RANKL- and TNF-induced osteoclastogenesis pathways, thereby mediates bone resorption in pathological bone loss conditions (By similarity). Required for TNFSF11/RANKL-induced osteoclastogenesis via its interaction with TNFRSF11A/RANK, thereby facilitates the downsteam transcription of NFATC1 and activation of PLCG2 (By similarity). Facilitates recruitment of the transcriptional repressor PRDM1/BLIMP1 to the promoter of the anti-osteoclastogenesis gene IRF8, thereby resulting in transcription of osteoclast differentiation factors (By similarity). May play a role in estrogen action . . |
Accessions | Q5T9C2 ENST00000373095.6 [Q5T9C2-1] ENST00000373084.8 [Q5T9C2-3] |